Results 241 to 250 of about 14,304 (250)

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis

Lung Cancer, 2007
Birgitte Vrou Offersen, Per Pfeiffer, Peter Andreasen   +2 more
exaly  

Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner

Journal of Cell Biology, 1999
Andrew D Catling, Lori A Walker, Avril V Somlyo   +2 more
exaly  

Urokinase-Type Plasminogen Activator Receptor

2012
openaire   +1 more source

The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies

Expert Opinion on Therapeutic Targets, 2016
Shih-Chi Su, Chiao-Wen Lin, Wen-Lang Fan   +2 more
exaly  

Urokinase-Type Plasminogen Activator Receptor

2018
openaire   +1 more source

Structural Basis of Interaction between Urokinase-type Plasminogen Activator and its Receptor

Journal of Molecular Biology, 2006
Cyril Barinka, David E Shaw, Alice Kuo
exaly  

Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: Role of oxygenation status and tumour size

British Journal of Cancer, 2002
Martin Weinmann, Oliver Thews, Peter Vaupel   +2 more
exaly  

Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II–Induced Abdominal Aortic Aneurysm

Circulation Research, 2003
Baby Martin-Mcnulty, Meredith Halks-Miller, David J Loskutoff   +2 more
exaly  

Urokinase Plasminogen Activator and Its Inhibitor Type‐1 as Prognostic Factors in Differentiated Thyroid Carcinoma Patients

Otolaryngology - Head and Neck Surgery, 2013
exaly  

Small molecule inhibitors of urokinase-type plasminogen activator

Expert Opinion on Therapeutic Patents, 2003
exaly